Summit Therapeutics Inc

$13.88
Market Cap 10.76B
ROE -291.2%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 7.4
Revenue QoQ 0.0%
EPS QoQ 1.0%
F-Score 2

About

No Description Available

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-9.01
vs median 15.30
P/B
19.90
vs median 3.52
ROE
-2.91
vs median 0.21

Lower quality - review fundamentals carefully

Large-cap company with established market presence

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics